Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Counterion-Enhanced Brightness of Fluorous-Soluble Heptamethine Cyanine Dyes for Near- and Shortwave Infrared Fluorescence Imaging.
Journal: Chemical & biomedical imaging
Published: December 31, 2025
Counterion Exchange Enhances the Brightness and Photostability of a Fluorous Cyanine Dye.
Journal: Chemistry (Weinheim an der Bergstrasse, Germany)
Published: July 01, 2024
Indirect Costs of Alzheimer's Disease: Unpaid Caregiver Burden and Patient Productivity Loss.
Journal: Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research
Published: June 03, 2024
Promoting diversity in clinical trials: insights from planning the ALUMNI AD study in historically underrepresented US populations with early symptomatic Alzheimer's disease.
Journal: EClinicalMedicine
Published: December 22, 2023
Spectrally Selective Time-Resolved Emission through Fourier-Filtering (STEF).
Journal: The journal of physical chemistry letters
Published: January 11, 2023
An expanded access program of risdiplam for patients with Type 1 or 2 spinal muscular atrophy.
Journal: Annals of clinical and translational neurology
Published: January 20, 2022
Safety, Tolerability, and Pharmacokinetics of Crenezumab in Patients with Mild-to-Moderate Alzheimer's Disease Treated with Escalating Doses for up to 133 Weeks.
Journal: Journal of Alzheimer's disease : JAD
Published: June 23, 2020
Pharmacokinetics and pharmacodynamic effect of crenezumab on plasma and cerebrospinal fluid beta-amyloid in patients with mild-to-moderate Alzheimer's disease.
Journal: Alzheimer's research & therapy
Published: August 23, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026